Eliel Bayever

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Nanomedicine, Oncology, Pancreatic Cancer +8

Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

Ramesh K. Ramanathan, Ronald L. Korn, Natarajan Raghunand et al. · Clinical Cancer Research · 2017 · 171 citations

Systemic Administration of a Phosphorothioate Oligonucleotide with a Sequence Complementary to p53 for Acute Myelogenous Leukemia and Myelodysplastic Syndrome: Initial Results of a Phase I Trial

Eliel Bayever, Patrick L. Iversen, Michael Bishop et al. · Antisense Research and Development · 1993 · 149 citations

Hematological Malignancy, Synthetic Phosphorothioate Oligonucleotide, Medicine +14

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.

Michael Bishop, Patrick L. Iversen, Eliel Bayever et al. · Journal of Clinical Oncology · 1996 · 141 citations

BONE-MARROW TRANSPLANTATION FOR METACHROMATIC LEUCODYSTROPHY

Eliel Bayever, Michel Philippart, Marc R. Nuwer et al. · The Lancet · 1985 · 81 citations

Transplantation, Marrow Transplantation, Bone Marrow Failure +4